Full Text (PDF)
Journal of Microbiology and Related Research 8(1):p 13-15, January-June 2022. | DOI: https://doi.org/10.21088/jmrr.2395.6623.8122.2
Original Article
Severe Plasmodium Falciparum Malaria and Severe Plasmodium Vivax Malaria Treatment in India
Author Information
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
Journal of Microbiology and Related Research 8(1):p 13-15, January-June 2022. | DOI: https://doi.org/10.21088/jmrr.2395.6623.8122.2
How Cite This Article:
Arvind Nath/ Severe Plasmodium Falciparum Malaria and Severe Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 13–15.Timeline
Received : May 13, 2022
Accepted : June 01, 2022
Published : June 25, 2022
Abstract
Background: The treatment of severe P. falciparum Malaria and severe P. vivax Malaria is identical. Their treatment in India is complex because different regimes exist for the North-eastern part of the country and for the rest of the country. Also, different drugs are needed for the treatment of pregnant patients. oBjectives: To find out what are the antimalarials prescribed in India for treating severe Falciparum Malaria and severe Vivax Malaria. Methods: By reviewing documents prepared by NVBDCP. results: It is found that different regimes exist for treating severe Falciparum Malaria and severe Vivax Malaria depending on where the patient comes from, and the drugs differ based on the pregnancy status of the female patient. conclusions: More education is required among health care providers on how to treat severe P. falciparum Malaria and severe P. vivax Malaria. This paper addresses this concern.
References
- 1. Government of India.(2014). Guidelines for Diagnosis and Treatment of Malaria in India 2014. Available at https://nvbdcp.gov.in/ WriteReadData/l892s/20627628441542176662.pdf Accessed on 29 December 2021.
- 2. Government of India. (2013) National Drug Policy on Malaria 2013. Available at https://nvbdcp. gov.in/WriteReadData/l892s/National-DrugPolicy-2013.pdf Accessed on 14 September 2021.
- 3. Government of India. (2009) Guidelines for Establishing Sentinel Surveillance Hospitals and Management of Severe Malaria Cases. Available at https://nvbdcp.gov.in/Doc/SSH_Management_ Malaria_update.pdf Accessed on 11 January 2022.
- 4. Government of India (2016) Operational Manual for Malaria Elimination in India 2016 (Version 1). Available at https://nvbdcp.gov.in/ WriteReadData/l892s/5232542721532941542.pdf Accessed on 4 August 2021.
- 5. Government of India. National Framework for Malaria Elimination in India 2016 – 2030. Available athttps://nvbdcp.gov.in/WriteReadData/l892s/ National-framework-for-malaria-elimination-inIndia-2016%E2%80%932030.pdf Accessed on 11 February 2016.
- 6. World Health Organization. Global Technical Strategy for Malaria 2016 – 2030. Available athttps://www.who.int/publications/i/ item/9789240031357 Accessed on 17 September 2021.
- 7. Government of India. Annual Report of National Vector-Borne Disease Control Programme 2018. Available athttps://nvbdcp.gov.in/Doc/AnnualReport-2018.pdf Accessed on 25 August 2021.
Data Sharing Statement
There are no additional data available. All raw data and code are available upon request.
Funding
This research received no funding.
Author Contributions
All authors contributed significantly to the work and approve its publication.
Ethics Declaration
This article does not involve any human or animal subjects, and therefore does not require ethics approval.
Acknowledgements
We would like to express our gratitude to the patients, their families, and all those who have contributed to this study.
Conflicts of Interest
No conflicts of interest in this work.
About this article
Cite this article
Arvind Nath/ Severe Plasmodium Falciparum Malaria and Severe Plasmodium Vivax Malaria Treatment in India/J Microbiol Relat Res. 2022;8(1): 13–15.
Licence:
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
| Received | Accepted | Published |
|---|---|---|
| May 13, 2022 | June 01, 2022 | June 25, 2022 |
DOI: https://doi.org/10.21088/jmrr.2395.6623.8122.2
Keywords
MalariaPlasmozzdium falciparumPlasmodium vivaxSearch for Similar Articles
Similar Articles
- Ochrobactrum anthropi Bacteremia in Immunocompromised Patients: A Unique Threat...
- A Survey of Current Research on the Green Synthesis of Silver Nanoparticles (AgN...
- Navigating the Global Obesity a Global Catastrophe: The Role of Pancreatic Lipas...
- Phenotypic Detection of MRSA from Conventional Methods and CHROM Agar Medium in...
- Isolation of Exopolysaccharides Producing Microorganisms from Garden Soils
Article Level Metrics
Last UpdatedMonday 21 September 2026, 14:27:18 (IST)
1469
Accesses
3
188
00
Citations
NA
NA
NA
Download citation
Article Keywords
Keyword Highlighting
Highlight selected keywords in the article text.
Timeline
| Received | May 13, 2022 |
| Accepted | June 01, 2022 |
| Published | June 25, 2022 |
licence
Attribution-Non-commercial 4.0 International (CC BY-NC 4.0)
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format for noncommercial purposes only, and only so long as attribution is given to the creator.
